Your browser doesn't support javascript.
loading
Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan.
Yang, Chih-Chao; Ro, Long-Sun; Tsai, Nai-Wen; Lin, Chou-Ching; Huang, Wen-Nan; Tsai, Ching-Piao; Lin, Thy-Sheng; Su, Jen-Jen; Huang, Chin-Chang; Lyu, Rong-Kuo; Chen, Hsin-Hua; Lee, Wei-Ju; Chen, Po-Lin; Yang, Audrey.
Afiliação
  • Yang CC; Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: jesse6627@gmail.com.
  • Ro LS; Chang Gung Memorial Foundation-Linkou, Taiwan. Electronic address: cgrols@adm.cgmh.org.tw.
  • Tsai NW; Chang Gung Memorial Hospital-Kaohsiung, Taiwan. Electronic address: naiwen@adm.cgmh.org.tw.
  • Lin CC; National Cheng Kung University Hospital, Taiwan. Electronic address: cxl45@mail.ncku.edu.tw.
  • Huang WN; Neurological Institute, Taichung Veterans General Hospital, Taiwan. Electronic address: gtim5555@yahoo.com.
  • Tsai CP; Taipei Veterans General Hospital, Taiwan. Electronic address: cptsai@vghtpe.gov.tw.
  • Lin TS; National Cheng Kung University Hospital, Taiwan. Electronic address: tslin@mail.ncku.edu.tw.
  • Su JJ; Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: ntuhneuro@hotmail.com.
  • Huang CC; Chang Gung Memorial Foundation-Linkou, Taiwan. Electronic address: cch0537@adm.cgmh.org.tw.
  • Lyu RK; Chang Gung Memorial Foundation-Linkou, Taiwan. Electronic address: lyu5172@adm.cgmh.org.tw.
  • Chen HH; Neurological Institute, Taichung Veterans General Hospital, Taiwan. Electronic address: shc5555@hotmail.com.
  • Lee WJ; Neurological Institute, Taichung Veterans General Hospital, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. Electronic address: winster.lee@msa.hinet.net.
  • Chen PL; Neurological Institute, Taichung Veterans General Hospital, Taiwan. Electronic address: boring@mail2000.com.tw.
  • Yang A; Novartis (Taiwan) Co., Ltd., Taiwan. Electronic address: audrey.yang@novartis.com.
J Formos Med Assoc ; 120(1 Pt 2): 542-550, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32669233

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cloridrato de Fingolimode / Esclerose Múltipla Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article